The Impact of COVID-19 is included in Stem Cell Assay Market. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
The future of the global stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes. The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028 with a CAGR of 19.1% from 2023 to 2028. The major drivers for this market are increasing awareness of the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.